Need to Growth Stock for 2022? Try Babylon Holdings!

We’re currently going through the third week of 2022. In a way, this is still a new year since we’ve barely seen any of it develop in full.

And what better way to celebrate a new year than to find new investment opportunities? What about some growth stocks? With them, you might find something you were not expecting at first. Something great.

Here’s a growth stock we think you’ll like: Babylon Holdings (NYSE:BBLN).

A Rapidly Growing Healthcare Company

Babylon Holdings is a health service provider that focuses on enabling virtual clinical operations for patients. This means they can get virtual access to healthcare professionals and get their prescriptions delivered right to their door.

Today, it provides its services to up to 24 million customers across all continents. If you were wondering, its market focus is currently on the U.S. and the U.K.

And if that wasn’t enough, keep in mind that they’ve yet to release their final report for 2021. Why is that important? Because management expects it to show a 305% increase in yearly revenue, that would amount to $321 million.

Plus, for 2022, management expects their revenue to double that amount. You heard that right, and they’re expecting up to $710 million in revenue by the end of 2022.

On the other hand, Babylon has made several partnerships that might improve the quality of its services, as well as its inner workings. Such partnerships include the likes of Palantir and Microsoft, and these alliances quickly become excellent prospects for further growth along the way.

Nowadays, Babylon is valued at around $2.4 billion. That’s somewhat small for a company belonging to the healthcare industry, but it might as well be a way for you to enter it at a relatively low cost. 

Just be patient enough, and you’ll see, Babylon is to become a force to be reckoned with.